Examkin

Soru

Zorluk: OrtaGynecologic Oncology

Match each patient's clinical presentation of biopsy-proven cervical carcinoma with the most appropriate primary management strategy.

  • A 28-year-old nulligravida; cervical conization reveals squamous cell carcinoma with 1.5-mm depth of stromal invasion, negative margins, and no lymphovascular space invasion.Observation and routine surveillance
  • A 34-year-old; examination shows a visible 1.5-cm exophytic cervical mass. Imaging confirms the lesion is confined to the cervix without parametrial or lymph node involvement.Radical hysterectomy with bilateral pelvic lymphadenectomy
  • A 45-year-old; examination under anesthesia reveals a 4-cm cervical lesion with nodular induration of the left parametrium not extending to the pelvic sidewall.Definitive concurrent chemoradiotherapy (cisplatin, external beam radiation, and brachytherapy)
  • A 60-year-old; imaging demonstrates a bulky cervical mass, bilateral hydronephrosis, and multiple new bilateral pulmonary nodules consistent with metastasis.Palliative systemic chemotherapy (e.g., platinum doublet with bevacizumab)

Cevap

Stage IA1 with negative cone margins matches with observation; Stage IB1 matches with radical hysterectomy; Stage IIB (parametrial involvement) matches with chemoradiotherapy; and Stage IVB (distant lung metastases) matches with palliative systemic chemotherapy.
Cervical cancer treatment is strictly dictated by its clinical stage. Microinvasive disease (Stage IA1) with clear margins on a prior conization requires no further intervention if the patient desires fertility preservation. Early macroscopic disease confined to the cervix (Stage IB1) is effectively managed with radical hysterectomy, which is preferred in young patients to allow for ovarian preservation. Locally advanced disease with parametrial involvement (Stage IIB) is unresectable; therefore, standard curative-intent treatment is definitive chemoradiation. Finally, distant metastatic disease (Stage IVB) warrants palliative systemic therapy.

Adım Adım Çözüm

1
Evaluate depth of invasion and fertility desires for early-stage microscopic disease.
Identifies the 28-year-old as Stage IA1 (fertility desired, negative cone margins).
Determines if conization is definitively therapeutic versus requiring further surgical resection.
2
Assess for macroscopic disease confined to the cervix.
Identifies the 34-year-old as Stage IB1.
Selects optimal surgical candidates where radical hysterectomy can effectively clear the disease while sparing ovaries.
3
Examine for parametrial or locoregional extension.
Identifies the 45-year-old as Stage IIB due to parametrial induration.
Parametrial invasion contraindicates surgical resection due to the high risk of positive margins, necessitating primary chemoradiation.
4
Identify distant metastatic spread.
Identifies the 60-year-old as Stage IVB due to pulmonary nodules.
Metastasis to distant organs shifts the treatment goal from curative intent to palliative systemic therapy.

Anahtar Kavram

Clinical staging and stage-directed management of cervical cancer
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru